Skip to content

Preanesthetic Analgesia/Nociception Index (ANI) and Propofol Injection Pain

Can Preanesthetic Analgesia/Nociception Index (ANI) Predict Propofol Injection Pain

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05049577
Enrollment
124
Registered
2021-09-20
Start date
2023-04-01
Completion date
2023-06-30
Last updated
2023-10-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Analgesia, Nociceptive Pain, Pain, Acute

Brief summary

Recently, Analgesia Nociception Index (ANI) has been evaluated for objectively measuring peri-operative pain and to guide intra-operative opioid administration during various surgeries. Propofol injection pain (PIP) is a common problem and can be very distressing to the patient.

Detailed description

This study aimed to the association of preanesthetic ANI scores and PIP in patients who scheduled for general anesthesia. Before propofol administration in remifentanil group, preanesthetic ANI values (instant and mean) were checked after remifentanil to a target Ce of 4 ng/ml. Control group received the same volume of saline as remifentanil group. Heart rate and bispectral index were checked as ANI. Point biserial correlation and ROC curve were analyzed.

Interventions

V1 and V5 electrocardiographic positions as per the manufacturer's recommendations. The ANI was continuously recorded and displayed with a frequency of 1 Hz. ANI scores measured immediately before propofol administration, half-dose administration (1mg/kg), and full-dose administration (2mg/kg)of propofol.

Sponsors

Wonkwang University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SCREENING
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Masking description

All study drugs were administered using a Minto pharmacokinetic model in a TCI device (Orchestra, Fresenius-Vial, France). The infusion pump was covered to blind the patients, investigator, and outcomes assessor

Intervention model description

Prospective randomized and controlled study

Eligibility

Sex/Gender
MALE
Age
19 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

* Male patients who scheduled for general anesthesia * Cognitive patients who could understand this study

Exclusion criteria

* Patients receiving β-receptor blockers, ketamine, clonidine, or any vasoactive substance (i.e. metaraminol, ephedrine) and patients receiving neostigmine, atropine or glycopyrrolate.

Design outcomes

Primary

MeasureTime frameDescription
The correlation of Analgesia/nociception Index (ANI) and Propofol injection pain (PIP)Immediately before administration of propofol (2mg/kg)The correlation of preanesthetic ANI scores and incidence of PIP.

Secondary

MeasureTime frameDescription
Incidence and severity of PIPduring anesthesia induction ( half-dose (1mg/kg) and full-dose of (2mg/kg) propofol administration)Incidence and severity with numeric rating scales( 0= no pain, 100=worst pain) of propofol injection pain
The correlation of Analgesia/nociception Index (ANI) and Propofol injection pain (PIP)Immediately before administration of propofol (2mg/kg)The correlation of preanesthetic ANI scores and severity of PIP.

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026